欧洲 · 宏观、外汇与加密 · Sharecast
Novo Nordisk lifts FY guidance amid continued momentum in GLP1s
Danish drug maker Novo Nordisk lifted its full-year guidance on Wednesday as it pointed to continued momentum in GLP1s.
在 Sharecast 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.sharecast.com)
